Streetbeat News

Products Services

LDOS

Leidos (NYSE:LDOS) has completed the full cloud deployment of the Department of Defense's Automated Biometrics Information System (ABIS). This is a significant step towards securing fully automated biometrics capabilities in the cloud, promising increased system availability and performance globally. The work was performed under the Biometrics Enabling Capability, Increment One (BEC-1) contract. The deployment has improved the efficiency of the Biometrically Enabled Watch List Dissemination Management Functionality (BDMF), reducing the time required to process biometric data from days to hours.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:09 pm

PEPG

PepGen is set to present preclinical non-human primate data supporting its Enhanced Delivery Oligonucleotide Platform at two upcoming conferences. The key highlights of the presentation have been announced.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:08 pm

GE

GE HealthCare and Mass General Brigham have co-developed an AI algorithm to predict missed care opportunities (MCO) and late arrivals, aiming to increase operational effectiveness and productivity. The algorithm, part of the Radiology Operations Module (ROM), was able to predict MCOs with up to 96% accuracy in preliminary tests. The collaboration is part of a 10-year commitment signed in 2017 to explore the use of AI in healthcare.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:08 pm

HYMC

Hycroft Mining Holding Corporation (NASDAQ:HYMC) has announced positive results from its Metallurgical Flotation Variability Study. The study confirms average flotation recoveries of 89% for gold and 93% for silver, an increase from 80% for both metals in the March 2023 Technical Report. The improved recoveries are due to modifications to the grind size, reagents, and retention time. The results will be used to design the Hycroft processing facility for the next phase of commercial operations.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:07 pm

GH

Guardant Health (GH) has received coverage for its Guardant Reveal product from Geisinger Health Plan. This could potentially increase the accessibility and usage of the product, leading to increased revenues for Guardant Health.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:06 pm

LSTA

Lisata Therapeutics announced that the interim futility analysis for the Phase 2b ASCEND trial of LSTA1 in metastatic pancreatic ductal adenocarcinoma will continue as planned without modification.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:05 pm

AMRX

Amneal Pharmaceuticals has received approval for its first product, Sevelamer Carbonate, in China and expects to launch it soon. The company also plans to launch Oseltamivir Phosphate in China this year, pending approval. Amneal has six more products under review in China and plans to register more over time. Since 2019, Amneal has been collaborating with Fosun Pharmaceuticals to bring key therapies to market in China.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:05 pm

AMRX

Amneal Pharmaceuticals has received approval from the FDA for its Abbreviated New Drug Application for Lisdexamfetamine Dimesylate Capsules in various dosages. This approval could potentially lead to increased revenues for the company.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:04 pm

CRM

Genesys and Salesforce (NYSE:CRM) have announced a strategic collaboration to launch a unified AI-powered customer experience and relationship management solution. The solution, called CX Cloud, integrates Genesys Cloud CX and Salesforce Service Cloud.

Portfolio Pulse from Benzinga Newsdesk

September 06, 2023 | 12:01 pm